Renal Pharmacology - Imig Flashcards
What is the mechanism of action of Mycophenolate Mofetil (MMF)?
Is it natively active?
Mechanism: competitive, reversible inhibitor of IMPDH, a critical enzyme in de-novo purine synthesis. Inhibits proliferation of B and T lymphocytes
Prodrug: MMF is activated to Mycophenolic Acid (MPA), its active form
Mycophenolate Mofetil:
- Method of administration?
- Route of metabolism?
- Half-life?
- Adverse effects?
- oral or IV
- liver metabolism
- long half-life (18 hours)
- Adverse effects:
- hypertension, edema, tachycardia
- dyspnea, cough
- dizziness, insomnia, tremor, seizures
- leucopenia, thrombocytopenia, anemia
- opportunistic infections (CMV, bacterial UTI, etc)
- lympoproliferative disease, cancer
Name some drugs that decrease MPA levels in the administration of mycophenolate mofetil (MMF)?
Is MMF affected by the administation of tacrolimus or sirolimus?
Decrease MPA levels: antacids, cholestyramine, sevelamer, FeSO, phenytoin, phenobarbital, corticosteroids, cyclosporine
No change in MPA levels with tacrolimus or sirolimus
Describe the mechanism of action of azathioprine
Purine analogue. Metabolized by the liver to 6-MP, then TIMP. Decreases synthesis of DNA and also incorporates into DNA. Also blocks CD28 co-stimulation of T-cells.
What are some similar alternatives to azathioprine?
methotrexate
cyclophosphamide
Azathioprine:
- Route of administration?
- Half life?
- Unwanted side effects?
- oral
- short (3-5 hours)
- Unwanted side effects:
- bone marrow suppression (leukopenia, thrombocytopenia)
- hypersensitivity reactions (malaise, dizziness, fever, rash, GI issue, hypotension)
- opportunistic infections
- alopecia
- small lymphoma risk
Why should you use caution when administering allopurinol with azathioprine?
Allopurinol decreases 6-MP metabolism -> reduce azathioprine dose by 75% if used together
Discuss the clinical monitoring implications of azathioprine and MMF
Both: monitor CBC regularly for hematologic side effects
MMF: monitor for GI effects and consider lower dose / more frequenct administration to relieve this side effect
Name (3) IL-2 receptor antibody drugs used in renal transplant
Basiliximab - anti-CD25 chimeric
Daclizumab - anti-CD25 humanized
Alemtuzumab - anti-CD52 humanized
Basiliximab
- Route of administration?
- half life?
- Use?
- Adverse effects
- IV
- very long (1 week)
- inductive transplant agent given immediatly prior to surgery and 4 days following surgery
- (rare) hypersensitivity reaction
Belatacept
- route of administration
- mechanism of action
- therapeutic use
- half life
- unwanted side effects
- IV
- Binds CD80/86 -> blocks co-stimulatory step of T-cell activation
- Renal transplant for EBV-seropositive patients
- very long (8-10 days)
- unwanted side effects:
- (rare) hypersensitivity reaction
- lymphoproliferative disorder in patients w/ no prior EBV exposure
Discuss the therapeutic effects of prednisolone administration in renal transplant
Are its effects fast of slow?
- inhibits NF-kB (pro-inflammatory transcription factor)
- Activates anti-inflammatory genes
- Reduce T-cell proliferation and increase T-cell apoptosis
These effects are slow: >8 hours (transcription and protein synthesis.
What is an important interaction to consider when using corticosteroids with other typical transplant drugs?
Interactions with calcineurin inhibitors (CNIs) - may potentiate adverse effects
Name some possible side effects of corticosteroid use
acne
cushingoid facies
hirsutism
mood disorders
hypertension
glucose intolerance
cataracts
osteoporosis
growth retardation (children)
Due to advances in immunosuppression, what is the typical longevity in renal allografts?
10-15 years. Sometimes 20.
What are the two general categories of agents used in an overall transplant rejection suppression strategy?
Induction agents - monoclonal or polyclonal antibodies administered immediately before/after surgery
Maintenence agents - corticosteroids, CINs, anti-proliferative agents
What drug class forms the ‘cornerstone’ of immunosuppressive maintenence therapy?
Calcineurin inhibitors (CINs)
What is an important physiological parameter to monitor when using induction agents?
Check fluid volume status
Describe the recent trends in usage of the following in renal transplant:
- cyclosporin or tacrolimus
- MMF or AZA
- mTOR inhibitors
- corticosteroids
- tacrolimus used more -> cyclosporine falling out of use
- MMF used more -> AZA falling out of use
- mTOR inhibitors generally used less
- Corticosteroids are generally used less
With respect to RAAIs and corticosteroids/immunosuppressants, give the treatment indication for the following:
- IgA nephropathy
- Nephrotic syndrome
- Membranous nephropathy
- Focal Segmental Glomerulosclerosis
- Lupus Nephritis
- Anti-GBM/Goodpasture’s
- ACE-I, corticosteroids or immunosuppressants
- ACE-I or ARB
- ACE-I or ARB, corticosteroids or immunosuppressants
- ACE-I, corticosteroids or immunosuppressants
- Corticosteroids (class V)
- Corticosteroids
Summarize several possible approaches to preventing renal transplant rejection.
Calcineurin inhibition
mTOR inhibition
Anti-proliferatives
T-cell depleting mAbs
What is the mechanism of action of cyclosporine?
How is it administered and metabolized?
Binds cyclophilin to inhibit calcineurin, leads to decreased IL-2 and T-cell proliferation.
Oral/IV (+ophthalmic?), concentrates in various tissues (~27hr half-life) and metabolized by CYP3A4 in liver.
What are the side effects associated with cyclosporine? (lol)
Nephrotoxicity (vasoconstriction, TGFb, fibrosis, tubular atrophy)
HTN & fluid retention
Hepatic dysfunction
N/V/D, Headache, Fatigue, Tremor
Hypertrichosis, Gum hypertrophy
Hyperlipidemia, hypomagnesemia, hypokalemia.
What drugs should be avoided with cyclosporine treatment?
Is this drug commonly used?
Anything nephrotoxic (NSAIDs, AMGs), and CYP inhibitors (too many to actually list)
No, it has been largely replaced by tacrolimus because of its poor SE profile and poor compliance.